A carregar...
28-Year Survival following Several Metastasectomies, Going through 8th Line Systemic Therapy in a Case of mRCC
Metastatic renal cell carcinoma (mRCC) has been one of the most treatment-resistant cancers because of its unpredictable clinical course, resistance to chemo- and radiotherapy, and the limited response to immunotherapy and targeted agents. We present a case of long-term survival, that is, 28 years,...
Na minha lista:
| Publicado no: | Case Rep Urol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4355604/ https://ncbi.nlm.nih.gov/pubmed/25810943 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/523258 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|